![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
S-collate cohort 'real-life' study: efficacy and safety of peginterferon alfa-2a (40KD) in 1233 patients with chronic hepatitis B according to Asian and Caucasian race
|
|
|
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Patrick Marcellin, Qing Xie, Teerha Piratvisuth, Graham R Foster, Robert Flisiak, XinYue Chen, Yao Xie, Yongping Chen, Seung Woon Paik, Diethelm Messinger, Loredana Regep, Heiner Wedemeyer
Service d'Hepatologie and INSERM CRB3/U773, University Paris-Diderot, Clichy, France
![EASL1.gif](../images/050913/050913-2/EASL1.gif)
![EASL2.gif](../images/050913/050913-2/EASL2.gif)
![EASL3.gif](../images/050913/050913-2/EASL3.gif)
![EASL4.gif](../images/050913/050913-2/EASL4.gif)
![EASL5.gif](../images/050913/050913-2/EASL5.gif)
![EASL6.gif](../images/050913/050913-2/EASL6.gif)
![EASL7.gif](../images/050913/050913-2/EASL7.gif)
![EASL8.gif](../images/050913/050913-2/EASL8.gif)
![EASL9.gif](../images/050913/050913-2/EASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|